SEC Form 4 · accession 0001179110-16-025879
AMAG PHARMACEUTICALS INC. · AMAG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julie Krop
Officer — SVP Clinical & Regulatory, CMO
Period of report
Jun 1, 2016
Accepted (ET)
Jun 2, 2016 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000792977
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2016 | F | 2,394 | $22.13 | D | 28,606 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 7,332 restricted stock units on June 1, 2016. 2,394 shares were withheld to satisfy the reporting person's applicable tax obligations.